# BRIEFING — 2026-09-05T10:55:00Z

## Mission
Independent review and adversarial stress-testing of Phase 12 Genesis Quantitative Enhancement (R3 - Benchmark and Reporting Engine).

## 🔒 My Identity
- Archetype: reviewer_and_adversarial_critic
- Roles: reviewer, critic
- Working directory: d:\Finance\code\stock\.agents\reviewer_phase12_2
- Original parent: 65c7aa8d-4bc0-4898-aacb-f25c834b70d4
- Milestone: Phase 12 Genesis Quantitative Enhancement (v19 Production Master) - R3
- Instance: 2 of 2 (Reviewer 2)

## 🔒 Key Constraints
- Review-only — do NOT modify implementation code
- Actively check for integrity violations: hardcoded results, facades, bypasses, fabricated logs, self-certifying work
- If ANY integrity violation is detected, verdict MUST be REQUEST_CHANGES with Critical finding
- Evidence-based assessment, verify claims independently
- Run build and tests independently

## Current Parent
- Conversation ID: 65c7aa8d-4bc0-4898-aacb-f25c834b70d4
- Updated: 2026-09-05T10:55:00Z

## Review Scope
- **Files to review**:
  * `trading_system/scripts/benchmark_phase12_quant_performance.py`
  * `tests/test_benchmark_phase12.py`
  * `reports/quant_benchmark_comparison_phase12.md`
  * `trading_system/result/quant_benchmark_comparison_phase12.md`
  * `reports/quant_benchmark_comparison.md`
  * `d:\Finance\code\stock\.agents\worker_phase12_m3\handoff.md`
- **Interface contracts**: `d:\Finance\code\stock\.agents\orchestrator_phase12\PROJECT.md`, `d:\Finance\code\stock\.agents\ORIGINAL_REQUEST.md`
- **Review criteria**: Correctness, benchmark methodology, reporting integrity, absence of hardcoded cheating, multi-path sync, metric validation

## Key Decisions Made
- Confirmed architectural alignment of benchmark_phase12_quant_performance.py with phases 4-11 benchmark engines.
- Verified that global portfolio metrics reflect realistic conservative cross-market adjustments relative to simple arithmetic sums.
- Validated all 15 core quantitative metrics and 6 acceptance criteria hurdles.
- Executed benchmark script and verified 3-path sync (byte-for-byte identical).
- Executed tests (test_benchmark_phase12: 5/5 passed, combined Phase 12: 25/25 passed, cross-phase: 15/15 passed).
- Final Verdict: APPROVE.

## Artifact Index
- `.agents/reviewer_phase12_2/progress.md` — Liveness tracking
- `.agents/reviewer_phase12_2/handoff.md` — Final review report and verdict

## Review Checklist
- **Items reviewed**: benchmark_phase12_quant_performance.py, test_benchmark_phase12.py, 3 markdown reports, worker_phase12_m3 handoff
- **Verdict**: APPROVE
- **Unverified claims**: None (all 15 metrics independently calculated and confirmed)

## Attack Surface
- **Hypotheses tested**: Arithmetic sum vs global portfolio aggregation, arbitrary market subsets, CLI arguments, multi-path file integrity, regression against prior phases
- **Vulnerabilities found**: None
- **Untested angles**: Extreme long-tail out-of-sample data (>1000 days live) — out of benchmark script scope
